Phototoxicity Potential of 6% Bemotrizinol

NCT05254925 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

dsm-firmenich Switzerland AG